Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Works To Stay Ahead Of Benzodiazepine Misuse
Sep 21 2021
•
By
Laura Helbling
NIH and FDA are keeping their eye out for products that could help patients withdraw from benzodiazepines. • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Drug Safety
More from Pink Sheet